News Aradigm Corporation

Equities

ARDMQ

US0385054004

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+6.73%	-25.81%

2020	Aradigm Corporation Went Out of Business	CI
2020	Modified Combined Liquidation Plan and Discosure Statement Approved for Aradigm Corporation	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aradigm Corporation Went Out of Business	29/20/29	CI
ARADIGM CORP : Other Events, Financial Statements and Exhibits (form 8-K)	16/20/16	AQ
Modified Combined Liquidation Plan and Discosure Statement Approved for Aradigm Corporation	12/20/12	CI
ARADIGM CORP : Other Events (form 8-K)	05/20/05	AQ
ARADIGM CORP : Other Events, Financial Statements and Exhibits (form 8-K)	30/20/30	AQ
Revised Disclosure Statement Conditionally Approved for Aradigm Corporation	27/20/27	CI
ARADIGM CORP : Other Events (form 8-K)	13/20/13	AQ
Combined Liquidation Plan and Disclosure Statement Filed by Aradigm Corporation	08/20/08	CI
Aradigm : Announces Sale of Assets to Grifols, S.A.	06/20/06	AQ
ARADIGM CORP : Other Events, Financial Statements and Exhibits (form 8-K)	04/20/04	AQ
Grifols, S.A. completed the acquisition of Assets and Intellectual Property of Lipoquin, Free Ciprofloxacin, Apulmiq from Aradigm Corporation (OTCPK:ARDM.Q).	31/20/31	CI
Motion for Asset Sale Approved for Aradigm Corporation	30/20/30	CI
ARADIGM CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	10/20/10	AQ
Bidding Procedure Approved for Aradigm Corporation	09/20/09	CI
Aradigm : Announces Entering into an Asset Purchase Agreement with Grifols, S.A	24/20/24	AQ
ARADIGM CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	21/20/21	AQ
Motion for Asset Sale Filed by Aradigm Corporation	21/20/21	CI
Grifols, S.A. entered into an asset purchase agreement to acquire Assets and Intellectual Property of Lipoquin, Free Ciprofloxacin, Apulmiq from Aradigm Corporation (OTCPK:ARDM.Q) for $6.3 million.	21/20/21	CI
Second Motion for Exclusivity Period Extension Approved For Aradigm Corporation	06/19/06	CI
Aradigm Corporation Announces Withdrawal of European Marketing Authorization Application for Linhaliq	31/19/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aradigm Corporation

Equities

ARDMQ

US0385054004

Summary

Filters